Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Wende Hutton - aVenture Research

Wende Hutton

AddedMar 31, 2024

UpdatedOct 13, 2026

Wende Hutton

Wende Hutton

Board Member, Altheos

Wende Hutton's Career

Altheos

Wende Hutton's Co-Investors

Tom HuttonCo-invested · MoCaFi Series A

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Wende Hutton's Investments

2 investments since 2015

2 operating

Investments view

Group by

2021

1

MoCaFi
Series A · February 2021$12M
Series A · February 2021

2015

1

Antiva Biosciences
Series B · August 2015$16M
Series B · August 2015

$32.5M

South San Francisco, CA, US

Board Member· Board

Minimally Invasive Devices

Public$47.1MColumbus, OH, US

Board Member· Board

Hyalex Orthopaedics

Series A$33MLexington, MA, US

Board Member· Board

Antiva Biosciences

Series E$141.3MSouth San Francisco, CA, US

Board Member· Board

Theraclone Sciences

Series B$63.2MSeattle, WA, US

Board Member· Board

Elitra Pharmaceuticals

Series B$22MSan Diego, CA, US

Board Member· Board

Aldea Pharmaceuticals

Series B$42MRedwood City, CA, US

Board Member· Board

Glooko

Series D$201MPalo Alto, CA, US

Board Member· Board

ReVision Optics

$194.9MLake Forest, CA, US

Board Member· Board

People Similar to Wende Hutton

John E. DowlingCo-Founder · Aldeyra Therapeutics

Thomas A. JordanCo-Founder · Aldeyra Therapeutics

Thomas DyrbergBoard Member · AlloCure

Alain SchreiberBoard Member · Medivate Partners

ilyas washingtonCo-Founder · Alkeus Pharmaceuticals

Leadership at Altheos

Ken KengatharanCo-Founder

Rob HopfnerBoard Member

Lester 'Les' KaplanBoard Member

Henry H HsuBoard Member

Similar to Altheos

Altheus TherapeuticsOklahoma City, OK, USPharmaceuticalsest. 2006Altheus TherapeuticsOklahoma City, OK, US · est. 2006

Altheus Therapeutics: Innovating bowel disease treatment with Zoenasa tablets and rectal gels.

Public · $10.1M7

Leadership at Minimally Invasive Devices

Mike HoovenBoard Member

Jordan S. DavisBoard Member

Fred M. SchwarzerBoard Member

Brent AhrensBoard Member

Wayne PollFounder

Jeff RydinBoard Member

Similar to Minimally Invasive Devices

Agile EndoSurgeryChapel Hill, NC, USSurgical Instrumentsest. 2010Agile EndoSurgeryChapel Hill, NC, US · est. 2010

Agile EndoSurgery, based in Durham, US, develops advanced surgical tools to enhance minimally invasive surgery.

Seed · $258.7k5

Leadership at Hyalex Orthopaedics

Bill HarringtonBoard Member

Lampros KourtisCo-Founder

Renee RyanBoard Member

David MyungCo-Founder

Similar to Hyalex Orthopaedics

BiomimedicaBerkeley, CA, USMedical Devicesest. 2007BiomimedicaBerkeley, CA, US · est. 2007

Biomimedica, Inc.: A medical device company innovating synthetic cartilages for advanced joint repairs.

Angel · $15.4M6

Leadership at Antiva Biosciences

Gail MaderisBoard Member

Jenny YipBoard Member

Kristine BallBoard Member

Vinzenz PloererBoard Member

Karl HostetlerFounder

Steven JamesBoard Member

Similar to Antiva Biosciences

Kovina TherapeuticsIndianapolis, IN, USAntiviral Therapeuticsest. 2020Kovina TherapeuticsIndianapolis, IN, US · est. 2020

Kovina Therapeutics: A preclinical biotech firm developing first-in-class antiviral therapies for HPV-related conditions.

Leadership at Theraclone Sciences

Chris MirabelliBoard Member

Johnny StineFounder

Steve GillisBoard Member

Similar to Theraclone Sciences

BioClonetics ImmunotherapeuticsRockwall, TX, USAntibodies, Biopharmaceuticalsest. 2009BioClonetics ImmunotherapeuticsRockwall, TX, US · est. 2009

BioClonetics: A biotech firm developing and producing monoclonal antibodies to combat infectious diseases.

Public · $255.6k6

IdbiologicsNashville, TN, USAntibodies, Therapeuticsest. 2017IdbiologicsNashville, TN, US · est. 2017

IDBiologics: Pioneering infectious disease treatment through rapid discovery and optimization of human monoclonal antibodies.

Trellis BioscienceSan Francisco, CA, USAntibody Treatmentsest. 1998Trellis BioscienceSan Francisco, CA, US · est. 1998

US-based Trellis Bioscience develops therapeutic antibody treatments for infectious diseases and cancer.

Series B · $28.6M75

Abterra BiosciencesSan Diego, CA, USAntibody Therapeuticsest. 2009Abterra BiosciencesSan Diego, CA, US · est. 2009

Abterra Bio: Pioneering next-gen antibody therapeutics with advanced technology and machine learning.

Leadership at Elitra Pharmaceuticals

Judith ZyskindBoard Member

J Gordon FoulkesBoard Member

Dr Charles C HsuBoard Member

Similar to Elitra Pharmaceuticals

Elite PharmaceuticalsNorthvale, NJ, USPharmaceuticalsest. 1996Elite PharmaceuticalsNorthvale, NJ, US · est. 1996

Elite Pharmaceuticals innovates and manufactures controlled-release pharmaceuticals, specializing in pain management.

Public · $7.5M53

BiorelixNew Haven, CT, USAntibiotics, Pharmaceuticalsest. 2005BiorelixNew Haven, CT, US · est. 2005

BioRelix Inc: A leading manufacturer and distributor of innovative antibiotic drugs and riboswitch-based therapies.

Public · $40.7M30

Taxis PharmaceuticalsMonmouth Junction, NJ, USPharmaceuticalsest. 2009Taxis PharmaceuticalsMonmouth Junction, NJ, US · est. 2009

TAXIS Pharmaceuticals Inc., a biopharmaceutical firm specializing in developing drugs for resistant bacterial pathogens.

Seed · $6.2M28

EndolytixBeverly, MA, USTherapeuticsest. 2020EndolytixBeverly, MA, US · est. 2020

Endolytix: A biotech firm innovating therapies for resistant antibiotic infections.

Series A · $16.3M16

Leadership at Aldea Pharmaceuticals

Wenjin YangFounder

Similar to Aldea Pharmaceuticals

Amygdala NeurosciencesPalo Alto, CA, USBiopharmaceuticalsest. 2015Amygdala NeurosciencesPalo Alto, CA, US · est. 2015

Amygdala Neurosciences Inc: A California-based biopharmaceutical company.

Series A · $8.9M30

Aldeyra TherapeuticsBurlington, MA, USEye Disease Treatmentsest. 2004Aldeyra TherapeuticsBurlington, MA, US · est. 2004

Aldeyra Therapeutics develops treatments for age-related macular degeneration, aiming to prevent blindness.

Public · $4.8M5

Alkeus PharmaceuticalsBoston, MA, USPharmaceuticals, Therapeuticsest. 2011Alkeus PharmaceuticalsBoston, MA, US · est. 2011

Alkeus Pharmaceuticals: A Boston-based startup innovating treatments for serious eye conditions.

Series B · $150.1M15

Alavita PharmaceuticalsMountain View, CA, USPharmaceuticalsest. 2005Alavita PharmaceuticalsMountain View, CA, US · est. 2005

Alavita Pharmaceuticals Inc.: Innovating in drug industry to reduce organ transplant failure.

Pre-Seed · $600k5

Leadership at Glooko

Charles BooradyBoard Member

Yogen DalalBoard Member

Sunny MadraCo-Founder

Chamath PalihapitiyaCo-Founder

Alfonso ZuluetaBoard Member

Russ JohannessonBoard Member

Similar to Glooko

GlumetricsIrvine, CA, USGlucose Monitors, Medical Devicesest. 2005GlumetricsIrvine, CA, US · est. 2005

GluMetrics Inc.: A US-based medical device company specializing in innovative glucose monitoring solutions.

Series C · $68.2M30

Recent news

Raindrop Corneal Inlay Complications May Result in Haze, Vision Problems: FDAAboutLawsuits.com · 2018

Why ReVision Optics Shut DownOphthalmology Innovation Source · 2018

ReVision Optics goes out of businesshealio.com · 2018

Leadership at ReVision Optics

Hansen A. YuanFounder

Inna EitanBoard Member

Mikhail GetmanBoard Member

Jay HolmesBoard Member

Frank FischerBoard Member

Brian DoveyBoard Member

Similar to ReVision Optics

ReaLensAustin, TX, USOphthalmic Devicesest. 2008ReaLensAustin, TX, US · est. 2008

ReaLens, LLC: Innovating in ophthalmic devices with a patented Iris Expander and a unique IntraOcular Lens, enhancing vision for the aging population.

Angel · $100k3k

Alkeus PharmaceuticalsBoston, MA, USPharmaceuticals, Therapeuticsest. 2011Alkeus PharmaceuticalsBoston, MA, US · est. 2011

Alkeus Pharmaceuticals: A Boston-based startup innovating treatments for serious eye conditions.

Series B · $150.1M15

Ocular TherapeutixBedford, MA, USOphthalmic Therapiesest. 2006Ocular TherapeutixBedford, MA, US · est. 2006

Ocular Therapeutix, Inc.: Global biopharma innovator in hydrogel-based ophthalmic therapies.

Public · $386.5M274

GlaukosSan Clemente, CA, USMedical Devicesest. 1998GlaukosSan Clemente, CA, US · est. 1998

Glaukos Corp: A public ophthalmic tech firm developing and marketing micro-scale therapies for glaucoma.

Public · $121M783

Cambridge Endoscopic DevicesFramingham, MA, USMedical Devicesest. 2004

Cambridge Endoscopic DevicesFramingham, MA, US · est. 2004

Cambridge Endoscopic Devices: Innovating hand-held laparoscopic instruments for enhanced medical procedures.

Series A · $9.1M30

EndolumikMorgantown, WV, USSurgical Devicesest. 2020EndolumikMorgantown, WV, US · est. 2020

Endolumik develops fluorescence-guided surgical visualization devices to enhance laparoscopic and robotic esophagogastric procedures.

SanovasSan Rafael, CA, USSurgical Toolsest. 2009SanovasSan Rafael, CA, US · est. 2009

Sanovas, Inc. develops and offers minimally invasive surgical tools for complex medical procedures in the US.

Series A · $9.2M39

Sparta BiomedicalMadison, NJ, USMedical Devicesest. 2017

Sparta BiomedicalMadison, NJ, US · est. 2017

Sparta Biomedical: Enhancing orthopaedic solutions to restore patient mobility, based in Madison, NJ.

Seed · $5M33

CartilageIrvine, CA, USMedical Devicesest. 2019CartilageIrvine, CA, US · est. 2019

Founded in 2019, Cartilage develops products to heal large and focal cartilage defects.

Flex BiomedicalMadison, WI, USBiotech Productsest. 2007Flex BiomedicalMadison, WI, US · est. 2007

Flex Biomedical: U.S. provider of biotech products and services for orthopedic treatment.

Pre-Seed · $4.4M6

Antios TherapeuticsAtlanta, GA, USAntiviral Therapiesest. 2018

Antios TherapeuticsAtlanta, GA, US · est. 2018

Antios Therapeutics: A global, clinical-stage biopharmaceutical company developing novel antiviral therapies.

Public · $200.4M35

RetroviroxSan Diego, CA, USAntiviral, Therapiesest. 2008RetroviroxSan Diego, CA, US · est. 2008

RetroVirox, a San Diego-based biotech firm, innovates in antiviral treatments and offers cell-based screening services.

Anviro TherapeuticsOrem, UT, USAntiviral Treatmentsest. 2015Anviro TherapeuticsOrem, UT, US · est. 2015

Anviro Therapeutics develops broad-spectrum antiviral treatments for global infectious diseases, leveraging BYU-discovered technology.

DexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999

DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k

DarioHealthNew York City, NY, USDiabetes Management, Health Trackingest. 2011DarioHealthNew York City, NY, US · est. 2011

DarioHealth: Leading in personalized health management with smart diabetes solutions.

Public · $233.3M252

Integrity ApplicationsAshkelon, Southern District, ILMedical Devicesest. 2010Integrity ApplicationsAshkelon, Southern District, IL · est. 2010

GlucoTrack, Inc.: Innovating non-invasive glucose monitoring devices for diabetes care in the US and Israel.

Public · $50.7M5

OvitzRochester, NY, USMedical Devicesest. 2013

OvitzRochester, NY, US · est. 2013

Ovitz: Precision optical measurement devices for custom contact lens production.

Seed · $1M30

Visus TherapeuticsSeattle, WA, USEye Dropsest. 2019Visus TherapeuticsSeattle, WA, US · est. 2019

Visus Therapeutics: Pioneering presbyopia-correcting eye drops with 8-hour potential.

Series B · $56M45

STAAR SurgicalMonrovia, CA, USEye Surgery Products, Implantable Lensesest. 1982STAAR SurgicalMonrovia, CA, US · est. 1982

STAAR Surgical, a US-based company, develops and manufactures high-quality visual implants and lenses for vision disorders and surgeries.